Response to the Clinical Treatment of Tubal Pregnancy

Not Applicable

Recruiting

• Conditions: Tubal Pregnancy; C13.703

• Registration Number: RBR-7nkf8tn
• Lead Sponsor: niversidade Federal do Paraná

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-18
• Last Update Posted: 29 May 2023
• Study Completion: 2024-10-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Stable patients diagnosed with ectopic pregnancy; beta-hCG levels below 5000 mU/mL; unruptured gestacional sac/mass; gestacional sac/mass below 4cm of length; no sign of fetal heartbeat on the ultrasound

Exclusion Criteria

Patients that don't fill the criteria for clinical treatment; patients who don't agree with the Informed Consent Form after reading and comprehending it

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We hope to find a reduced proportion of cases with gestacional sac rupture with endovenous administration of methotrexate, by verifyng at least 5% difference between control and intervention groups.

Secondary Outcome Measures

Name	Time	Method
We hope to observe similar rates of collateral offects between control and intervention groups, assessed by laboratory tests, verifying the safety of the new treatment method.